# Top 15 Biotechnology Angel Investors in Oceania in June 2026 ## Allan Moss - Type: Angel - Location: Sydney, New South Wales, Australia - Relevant deals: 2 - Stages: Series A, Seed - Focus: Health Care, Medical Device, Biotechnology Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005. ## Mike Wallas - Type: Angel - Location: Brisbane, Queensland, Australia - Relevant deals: 2 - Stages: Seed - Focus: Video, Water, Biotechnology Mike Wallas - Advisory Board @ Optifire Pty Ltd ## Adam Clark - Type: Angel - Location: Clearwater, Florida, United States - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Product Research Adam Clark is the Co-Founder, COO at Turncast. Adam Clark attended The Master's University. ## Benny Kleist - Type: Angel - Location: Sydney, New South Wales, Australia - Relevant deals: 1 - Stages: Pre-Seed, Series A - Focus: Education, E-Learning, Life Science Benny Kleist is a Founder & COO of Eucalyptus.He attended The University of Queensland. ## Anton Borzov - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: Information Technology, Artificial Intelligence, Medical Anton Borzov is the Product Designer at Neeva. ## Carl Stubbings - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Biotechnology Carl Stubbings is the Chief Commercial Officer at Genetic Technologies Limited. ## Richard Lipscombe - Type: Angel - Location: Perth, Western Australia, Australia - Relevant deals: 1 - Stages: Seed - Focus: Medical, Health Care, Biotechnology Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research). ## Serge van Dam - Type: Angel - Location: Wellington, Wellington, New Zealand - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Product Research Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor. ## Daniel Petre - Type: Angel - Location: Sydney, New South Wales, Australia - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: SaaS, Software, Health Care Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney. ## Paul Davidson - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: SaaS, FinTech, Privacy Paul Davidson joined private equity group, West Coast Capital in 2005 following a successful career in corporate law in the UK, the US and Commonwealth of Independent States. As an active partner in West Coast Capital as well as providing legal counsel, Paul focusses on deal sourcing and transacting.Since joining the group, Paul has successfulyled the acquisition and delisting from the LSE of the UK's largest garden centre business, Wyevale as well as a series of acquisitions and disposals.Prior to joining West Coast Capital headed the corporate team of UK lawyers, McGrigors.In late 1994 Paul was seconded to an oil and gas company called JKX whose focus was on the former Soviet Union, primarily in Ukraine, Georgia and the Russian Federation. JKX listed on the London Stock Exchange in mid 1995 and at that time Paul joined the company as its Legal Director on a full time basis. During his time as Legal Director, Paul gained wide commercial experience as the company concluded a number of transactions throughout the former Soviet Union. ## Latesha Randall - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Product Research Latesha Randall is the Co- Founder at Raglan Coconut Yoghurt. Latesha attended Homeschooled. ## Catherine Lacavera - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Medical, Health Care, Biotechnology Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto. ## Melanie Melanie - Type: Angel - Location: Wellington, Wellington, New Zealand - Relevant deals: 1 - Stages: Seed - Focus: Biotechnology, Product Research Investor ## David Ross - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Biopharma, Biotechnology David Ross ## Marko Bogoievski - Type: Angel - Relevant deals: 1 - Focus: Biotechnology, Manufacturing Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.